Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COPA: Effect of Cola on Velpatasvir Absorption with Omeprazole
NCT03513393Phase 1Completed
- Sponsor
- Radboud University Medical Center
- Start
- Aug 2018
- Primary completion
- Dec 2018
- Modality
- Reversible Covalent Inhibitors, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label trial of velpatasvir in hepatitis C (HCV) (3 arms), sponsored by Radboud University Medical Center. Primary endpoint: Bioequivalence Area Under the Curve from time zero to infinity at 21 days. Started Aug 2018; status: completed.
02
Drugs
velpatasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03513393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03513393.